Key facts
- AiTA’s last known valuation is $340.0M (Jan 2025).
- It has raised $24.5M; the latest was Later Stage VC ($10.0M) in Jan 2025.
- Notable investors include Hammerstone Capital, SkyView Investment Advisors, BlackPoint Capital Markets.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for AiTA
- ·The full record, as it builds
Funding rounds
No funding rounds for AiTA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AiTA
Developer of biology platform designed for the healthcare industry. The company's integrated micro-electro-mechanical systems augmented system integrates into treatment, diagnosis, and care for health issues, providing health companies with accessible technology for daily risks from life-threatening autoimmune disorders, aggressive cancers, addiction, and pain management.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Website
- aitabio.com/
- Ownership
- Privately Held (backing)
AiTA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AiTA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AiTA in its N-PORT filings yet. We sweep new filings monthly.